Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Avantor Performance Materials LLC
EIR
•Avantor Performance Materials LLC•April 14, 2021

Avantor Performance Materials LLC – FDA EIR, Apr 14, 2021

Record Details

An FDA routine Current Good Manufacturing Practice (cGMP) surveillance inspection of Avantor Performance Materials LLC, a pharmaceutical excipient and active pharmaceutical ingredient (API) repackager in Paris, KY, was conducted from April 7-14, 2021. This inspection, performed under Compliance Program 7356.002, identified several significant deficiencies. The main violations, formally cited in an FDA-483 observation, included inadequate and inconsistently performed preventative maintenance for equipment. Specifically, cleaning systems did not consistently meet required operating parameters, and production scale weight checks were not performed as stipulated. Furthermore, the company was cited for insufficient record-keeping for maintenance activities, with missing documentation for cleaning equipment and inadequate detail regarding contracted HEPA filter replacements. A critical finding was the absence of a secondary review to ensure the accuracy and completeness of various maintenance logs, including those for HEPA filters, water systems, cleaning equipment, and scale checks. Beyond these formal observations, the inspectors noted additional concerns, such as incomplete investigations into customer complaints that did not fully assess supplier involvement, a production employee failing to comply with gowning procedures (beard not fully covered), and the lack of formal quality agreements with third-party suppliers and outsourced laboratory services. Company management acknowledged these findings and committed to submitting a written response detailing corrective and preventative actions within 15 business days.

Company
Avantor Performance Materials LLC
Inspection date
April 14, 2021
Product type
Drugs
Office
Detroit District Office
People
  • Luiz Dias (company_representative)
  • William J. Moneypenny (recipient)
  • Steven P. Eastham (other)
  • Mark D. Featherston (company_representative)
  • Logan T. Williams (Investigator )
View Company Profile

ID · ac9577e7-28e9-4e7d-8e7f-d36351c00ad7

Violation Codes3
21 CFR 211.67(a)21 CFR 211.67(c)21 CFR 211.182

Full citation text and observation details available on the Dashboard.

Other documents for Avantor Performance Materials LLC
  • 483 - 2024-11-13November 13, 2024
  • 483 - 2021-04-14April 14, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Avantor Performance Materials LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.